Delivery Order SPE2DB24D1007-SPE2DB24FCABJ

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,913.64 firm-fixed-price contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat certain types of kidney disease. The contract has an ultimate completion date of September 24, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $22,931.11 and a period of performance through November 22, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,269.20 Firm Fixed Price Delivery Order contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to manage high phosphorus levels in patients with chronic kidney disease on dialysis. The contract has a completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,298.60, is for the delivery of Velphoro 500 mg chewable tablets. This contract does not have a set-aside designation, indicating it was open to full and open competition. The contract is a firm fixed price, delivery order contract that will run through August 25, 2023. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,063.39 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat certain kidney conditions. The contract has an ultimate completion date of April 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Velphoro 500 mg chewable tablets, a pharmaceutical product used for the treatment of hyperphosphatemia. The contract has a ceiling value of $5,384.31 and an ultimate completion date of May 19, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,105.51 delivery order contract is for the supply of Velphoro 500 mg chewable tablets, a medication used for the treatment of hyperphosphatemia. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. It is not designated as a set-aside contract, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $4,489.65 and is for a fixed-price delivery of the pharmaceutical product. The award date is October 15, 2024, and the ultimate completion date is October 16, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Velphoro 500 mg chewable tablets. The contract has a ceiling value of $3,940.95 and a completion date of May 15, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.48 firm fixed price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat certain types of kidney disease. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FCABJ
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,241.77 delivery order is for the supply of Velphoro 500 mg chewable tablets, a pharmaceutical product used to treat hyperphosphataemia in adult patients with chronic kidney disease on dialysis. The contract has an ultimate completion date of August 8, 2024 and does not utilize any set-aside designations. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range of essential medical commodities, including specialty medications, generic drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 11/6/24, 9:29 AM